GSK240927P40000
- 0.09
- 0.000.00%
GlaxoSmithKline Newsroom
Analysts Offer Insights on Healthcare Companies: GlaxoSmithKline (GB:GSK), Sonova Holding AG (Six Swiss: CH:SOON) and Corbus Pharmaceuticals (CRBP)
GlaxoSmithKline Sell Rating Justified by Earnings Concerns and Market Challenges
Jefferies Sticks to Their Buy Rating for GlaxoSmithKline (GSK)
Goldman Sachs Reaffirms Their Hold Rating on GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK) Gets a Hold From Barclays
Analyst Issues Sell Rating for GlaxoSmithKline Amid Market Share and Litigation Concerns
Berenberg Bank Maintains GlaxoSmithKline(GSK.US) With Buy Rating, Maintains Target Price $46
Deutsche Bank Keeps Their Buy Rating on GlaxoSmithKline (GSK)
Maintaining Sell Rating on GlaxoSmithKline: Analyzing COPD Market Challenges and Growth Concerns
Deutsche Bank Reaffirms Their Buy Rating on GlaxoSmithKline (GSK)
Analyst Issues Sell Rating for GlaxoSmithKline Amid Legal Challenges and Financial Risks
Barclays Remains a Hold on GlaxoSmithKline (GSK)
The latest pharmaceutical industry rating by S&P reveals that Johnson & Johnson (JNJ.US) and Roche (RHHBY.US) are ranked at the top for superior financial and innovative abilities.
Goldman Sachs Sticks to Its Hold Rating for GlaxoSmithKline (GSK)
Berenberg Bank Reaffirms Their Buy Rating on GlaxoSmithKline (GSK)
Berenberg Bank Keeps Their Buy Rating on GlaxoSmithKline (GSK)
Berenberg Bank Maintains GlaxoSmithKline(GSK.US) With Buy Rating, Maintains Target Price $46
Argus Research Remains a Buy on GlaxoSmithKline (GSK)
Moderna Stock Trading Lower On Dismal Guidance, Analysts Cuts Price Targets Noting Competitive Pressure From GSK, Pfizer
Citi Reaffirms Their Buy Rating on GlaxoSmithKline (GSK)